Inventaire - vos ami⋅e⋅s et communautés sont votre meilleure bibliothèque - Inventaire

Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition

publié dans: Biochemical Pharmacology

date de publication: 2007-10-15

langue: anglais

sujet principal: trouble du déficit de l'attention avec ou sans hyperactivité, attention

Articles cités 133

Date

Titre

Auteur·ices

2007-03-01

Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI)
2006-12-15

Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?

Alexandra Potter
2006-10-20

Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment
2006-08-23

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia

Guy Griebel, Alexandre Urani
2006-07-31

Brain nicotinic acetylcholine receptors: native subtypes and their relevance

Michele Zoli
2006-07-01

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity rela
2006-01-01

Selective alpha7 nicotinic acetylcholine receptor ligands
2006-02-23

ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study
2006-10-01

Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder

Stephen Faraone, Joseph Biederman, Larry J. Seidman, Alysa E Doyle, Carter R Petty, Ronna Fried, Jessie Fontanella
2006-07-01

(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
2006-02-01

The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination

Larry D Jamner, Jean-G Gehricke
2006-02-07

Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits
2005-12-01

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
2005-10-12

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization

Edward D Levin
2005-11-01

Acute effects of nicotine on attention and response inhibition
2005-10-01

Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults
2005-08-01

Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder.

Stephen Faraone, Joseph Biederman, Larry J. Seidman
2005-02-01

Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection

Michael Hasselmo
2004-12

Neuronal nicotinic receptors: from structure to pathology
2004-01-01

Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning

Marina Picciotto
2004

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders

Jeff S McDermott
2004

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder

Greg L Plosker
2004-01-01

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects
2004-04-09

Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder

Alexandra Potter
2004-01-01

DARPP-32: an integrator of neurotransmission

Jean-Antoine Girault, Angus C. Nairn, Paul Greengard, Per Svenningsson
2004-01-15

AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors
2004-08-01

Attention-deficit/hyperactivity disorder in adults

Stephen Faraone, Joseph Biederman
2004-07-01

Effects of nicotine on cognitive deficits in schizophrenia
2003-08-05

Executive and social behaviors under nicotinic receptor regulation

Jean-Pierre Changeux, Philippe Faure
2003-06-01

The worldwide prevalence of ADHD: is it an American condition?

Christopher Gillberg, Stephen Faraone, Joseph Biederman
2003-06-01

Attentional effects of nicotinic agonists in rats
2003-04-16

Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats

Ian P Stolerman

Article - wd:Q24614080

Bienvenue sur Inventaire

la bibliothèque de vos ami⋅e⋅s et communautés

vous n'êtes pas connecté